Eli Lilly (LLY +1.38%) and Novo Nordisk (NVO +1.03%) benefit from innovative treatments for obesity and diabetes.
*Stock prices used were the afternoon prices of Jan. 5, 2025. The video was published on Jan. 7, 2025.
Best Healthcare Stock to Buy: Eli Lilly vs. Novo Nordisk
By Parkev Tatevosian, CFA – Jan 8, 2025 at 10:29AM EST
NYSE: LLY
Eli Lilly
Market Cap
$1.0T
Today's Change
(1.38%) $14.56
Current Price
$1071.44
Price as of December 19, 2025 at 4:00 PM ET
Read Next
About the Author
A Fool since 2019, and a graduate of Cal State LA with a B.S. in Finance and M.A. in Economics. Parkev is an adjunct professor of Finance and enjoys reading about financial and economic history. You'll often find him writing about stocks in the consumer goods and technology sectors.
Stocks Mentioned
Eli Lilly
NYSE: LLY
$1071.44 (+0.01%) $+14.56
Novo Nordisk
NYSE: NVO
$48.10 (+0.01%) $+0.49
*Average returns of all recommendations since inception. Cost basis and return based on previous market day close.
Advertisement